Design and synthesis of a potent, selective, brain penetrate PDE9 inhibitor as a potential treatment for Alzheimer's disease

被引：0
|
作者：
Kang, Zhijun [1 ]
Helal, Christopher J. [1 ]
Claffey, Michelle M. [1 ]
机构：
[1] Pfizer Inc, Neurosci Med Chem, Groton, CT 06340 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2011年 / 241卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
56-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [21] ITI-214, a Potent and Selective PDE 1 Inhibitor: A New Approach to the Treatment of Neurodegenerative Diseases, Including Parkinson's Disease
    O'Brien, Jennifer J.
    Dutheil, Sophie
    Cruz, Stephanie
    Wennogle, Lawrence P.
    O'Gorman, Cedric
    Li, Peng
    Davis, Robert E.
    Snyder, Gretchen L.
    Hendrick, Joseph P.
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S405 - S406
  • [22] Synthesis, design and biological evaluation of novel highly potent tacrine congeners for the treatment of Alzheimer's disease
    Hamulakova, Slavka
    Janovec, Ladislav
    Hrabinova, Martina
    Kristian, Pavol
    Kuca, Kamil
    Banasova, Maria
    Imrich, Jan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 : 23 - 31
  • [23] Discovery of novel PDE9A inhibitors with antioxidant activities for treatment of Alzheimer's disease
    Zhang, Chen
    Zhou, Qian
    Wu, Xu-Nian
    Huang, Ya-Dan
    Zhou, Jie
    Lai, Zengwei
    Wu, Yinuo
    Luo, Hai-Bin
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2017, 33 (01) : 260 - 270
  • [24] A novel, highly potent and selective phosphodiesterase-9 inhibitor for the treatment of sickle cell disease
    McArthur, James G.
    Svenstrup, Niels
    Chen, Chunsheng
    Fricot, Aurelie
    Carvalho, Caroline
    Nguyen, Julia
    Phong Nguyen
    Parachikova, Anna
    Abdulla, Fuad
    Vercellotti, Gregory M.
    Hermine, Olivier
    Edwards, Dave
    Ribeil, Jean-Antoine
    Belcher, John D.
    Maciel, Thiago T.
    HAEMATOLOGICA, 2020, 105 (03) : 623 - 631
  • [25] Chemical synthesis of galantamine, an acetylcholinesterase inhibitor for treatment of Alzheimer's disease
    Marco-Contelles, J
    Rodriguez, C
    García, AG
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (05) : 575 - 587
  • [26] Novel salicylamide derivatives as potent multifunctional agents for the treatment of Alzheimer's disease: Design, synthesis and biological evaluation
    Song, Qing
    Li, Yan
    Cao, Zhongcheng
    Qiang, Xiaoming
    Tan, Zhenghuai
    Deng, Yong
    BIOORGANIC CHEMISTRY, 2019, 84 : 137 - 149
  • [27] CHDI-00340246, a potent and selective kynurenine monooxygenase inhibitor as potential therapeutic agent for the treatment of Huntington's disease
    Toledo-Sherman, Leticia
    Prime, Michael
    Mrzljak, Ladiskav
    Winkler, Dirk
    Khetarpal, Vinod
    Munoz-Sanjuan, Ignacio
    Dominguez, Celia
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [28] Design and Synthesis of PDE2A Inhibitors for the Treatment of Parkinson's Disease
    Wang, Yajing
    Liu, Jie
    Song, Guoqiang
    Yu, Yingcong
    Huang, Xianfeng
    CHEMISTRYSELECT, 2022, 7 (36):
  • [29] MEDI 288-Design and synthesis of potent gamma secretase inhibitors for the disease-modifying treatment of Alzheimer's Disease
    Harrison, Boyd
    Kreft, Anthony
    Alimardanov, Asaf
    Antane, Madeline
    Aschmies, Suzan
    Atchison, Kevin
    Casebier, David
    Chlenov, Michael
    Cole, Derek C.
    Comery, Thomas
    Diamantidis, George
    Ellingboe, John W.
    Fan, Kristi
    Gonzalez, Cathleen
    Hauze, Diane B.
    Hu, Yun
    Huryn, Donna
    Jain, Uday
    Jin, Mei
    Kubrak, Dennis
    Kutterer, Kristina
    Lin, Melissa
    Lu, Peimin
    Lundquist, Joseph
    Mann, Charles
    Martone, Robert
    Mayer, Scott C.
    Moore, William J.
    Oganesian, Aram
    Porte, Alex
    Resnick, Lynn
    Riddell, David
    Sonnenberg-Reines, June
    Stock, Joseph R.
    Sun, Shaiu-Ching
    Wagner, Eric
    Wang, Zhang
    Woller, Kevin
    Xu, Zheng
    Zaleska, Margaret
    Zhang, Minsheng
    Zhou, Hua
    Jacobsen, J. Steven
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
  • [30] Polyoxometalates as potent inhibitors for acetyl and butyrylcholinesterases and as potential drugs for the treatment of Alzheimer's disease
    Iqbal, Jamshed
    Barsukova-Stuckart, Maria
    Ibrahim, Masooma
    Ali, Syed Usman
    Khan, Aftab Ahmed
    Kortz, Ulrich
    MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (03) : 1224 - 1228
12345